Thromboembolic Events in the Hemodialysis Setting: Understanding Risk Profiles and Cumulative Incidences to Inform Clinical Trial Design.

MLA

Karaboyas, Angelo, et al. “Thromboembolic Events in the Hemodialysis Setting: Understanding Risk Profiles and Cumulative Incidences to Inform Clinical Trial Design.” Journal of the American Heart Association, vol. 14, no. 1, Jan. 2025, p. e033983. EBSCOhost, https://doi.org/10.1161/JAHA.124.033983.

APA

Karaboyas, A., Zhao, J., Tanko, L. B., Joergensen, K. T., Pap, A. F., Dasgupta, I., Nangaku, M., Jadoul, M., & Pecoits-Filho, R. (2025). Thromboembolic Events in the Hemodialysis Setting: Understanding Risk Profiles and Cumulative Incidences to Inform Clinical Trial Design. Journal of the American Heart Association, 14(1), e033983. https://doi.org/10.1161/JAHA.124.033983

Chicago

Karaboyas, Angelo, Junhui Zhao, Laszlo B Tanko, Kristian Tore Joergensen, Akos F Pap, Indranil Dasgupta, Masaomi Nangaku, Michel Jadoul, and Roberto Pecoits-Filho. 2025. “Thromboembolic Events in the Hemodialysis Setting: Understanding Risk Profiles and Cumulative Incidences to Inform Clinical Trial Design.” Journal of the American Heart Association 14 (1): e033983. doi:10.1161/JAHA.124.033983.